News & Events

Simpson Thacher represented Catalent, Inc. and Blackstone Healthcare Partners L.L.C., an affiliate of The Blackstone Group, L.P., in connection with a secondary offering of 16,100,000 shares of common stock (including 2,100,000 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares) at a public offering price of $29, resulting in gross proceeds of approximately $453 million to the selling stockholders. The initial offering closed on June 8, 2015 and the exercise of the overallotment option closed on June 11, 2015.

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

The Simpson Thacher team included Ed Tolley, Xavier Kowalski and Wenli Cai (Capital Markets); James Rapp (Public Company Advisory Practice); Aimee Adler and Holly Gurian (Executive Compensation and Employee Benefits); and Jodi Sackel (Tax). Summer Associate Seth Lowinger also provided invaluable assistance.